We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants

By LabMedica International staff writers
Posted on 22 Mar 2021
A joint project aims to establish an automated analytical system that enables mass diagnosis by early detection of viral disease prevalence and mutants, based on wastewater-based epidemiology.

Hokkaido University (Sapporo, Japan) and Robotic Biology Institute Inc. More...
(RBI; Tokyo, Japan), along with iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) for the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater.

It has been suggested that the novel coronavirus (SARS-CoV-2) can propagate by infecting intestinal epithelial cells. SARS-CoV-2 has been detected in the feces of a significant proportion of infected individuals including those without gastrointestinal symptoms. SARS-CoV-2 excreted in the feces of COVID-19 patients eventually come together at wastewater treatment plants. Therefore, research into wastewater-based epidemiology (WBE) of SARS-CoV-2, which acquires population-level epidemiological information by routine monitoring of the virus in wastewater, has been accelerating across the world. WBE has been reported in scientific papers to be extremely useful for early detection of the spread of COVID-19 and the confirmation of successful mitigation of the disease prevalence in a given region.

In Japan, there have been fewer reported cases of COVID-19 infection per capita compared to the US and some European countries and regions, and therefore, the concentrations of SARS-CoV-2 in Japanese wastewater tend to be lower than those in other countries. Hokkaido University and Shionogi had entered into a collaborative research agreement in October 2020 to develop a virus detection method with an increased sensitivity. As a result of the collaborative research, a highly sensitive method of SARS-CoV-2 detection in wastewater has been successfully developed.

For societal implementation of WBE, the establishment of a high throughput analysis system of the collected wastewater samples is urgently needed. For this purpose, RBI and iLAC have joined the existing collaborations between Hokkaido University and Shionogi. RBI has the technology for automated SARS-CoV-2 detection/quantification and library preparation for next-generation sequencing (NGS) analysis using LabDroid “Maholo,” a versatile humanoid robot made in Japan; iLAC is capable of elucidating genomic information (e.g., viral genome mutations) based on massive NGS analysis. They will help develop an automated analysis system for WBE of SARS-CoV-2.

Related Links:
Hokkaido University
Robotic Biology Institute Inc.



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.